Latest Breaking News On - Allosure heart - Page 1 : comparemela.com

CareDx (CDNA) – Research Analysts Recent Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of CareDx (NASDAQ: CDNA) in the last few weeks: 5/31/2024 – CareDx had its “neutral” rating reaffirmed by analysts at HC Wainwright. 5/29/2024 – CareDx was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating. 5/21/2024 – CareDx was upgraded […]

United statesCraig hallumRaymond jamesInvestment managementCaredx incBellevue groupVanguard group incNews ratings for caredx inc dailyGoldman sachs group incGagnon securitiesKent lake capitalGoldman sachs groupGet free reportAllosure kidneyAllomap heartAllosure heart

CareDx (NASDAQ:CDNA) Downgraded by StockNews com

StockNews.com lowered shares of CareDx (NASDAQ:CDNA – Free Report) from a buy rating to a hold rating in a research report sent to investors on Wednesday morning. Several other equities analysts have also recently weighed in on CDNA. HC Wainwright reiterated a neutral rating on shares of CareDx in a research note on Wednesday, May […]

United statesRaymond jamesCraig hallumFirst eagle investment managementPrincipal financial group incGoldman sachs groupCaredx incSwiss national bankCitigroup incFree reportModerate buyGet free reportFinancial groupNational bankEagle investment managementAllosure kidney

CareDx s (CDNA) Neutral Rating Reaffirmed at HC Wainwright

HC Wainwright reaffirmed their neutral rating on shares of CareDx (NASDAQ:CDNA – Free Report) in a report published on Friday, Benzinga reports. CDNA has been the topic of a number of other reports. StockNews.com cut CareDx from a buy rating to a hold rating in a research note on Wednesday. Raymond James downgraded CareDx from […]

United statesRaymond jamesCraig hallumQuest partnersCaredx company profileGoldman sachs groupCetera trust companyCaredx incNisa investment advisorsHeadlands technologiesFree reportModerate buyGet free reportInvestment advisorsAllosure kidneyAllomap heart

Landmark Study Shows CareDx s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies

Landmark Study Shows CareDx s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

United statesJohnw hannaKiran khushSurveillance heartcare outcomes registryAllosure heartCaredx presidentCardiovascular medicineAllomap heart

CareDx (NASDAQ:CDNA) Given New $22 00 Price Target at Craig Hallum

CareDx (NASDAQ:CDNA – Free Report) had its target price hoisted by Craig Hallum from $15.00 to $22.00 in a research note issued to investors on Friday morning, Benzinga reports. Craig Hallum currently has a buy rating on the stock. CDNA has been the topic of several other research reports. The Goldman Sachs Group raised their […]

United statesCraig hallumZurcher kantonalbank zurich cantonalbankRaymond jamesHeadlands technologiesGoldman sachs groupSherbrooke park advisersCaredx company profileNisa investment advisorsCaredx incFree reportModerate buyGet free reportInvestment advisorsKantonalbank zurich cantonalbankAllosure kidney